The invention provides oligonucleotide primers selected from the group consisting of a nucleotide sequence of the gag, vpr, and pol genes of HIV-1 Bru, HIV-1 Mal, HIV-1 Eli, HIV-2 ROD, and SIV MAC; the nef, vif, and vpx genes of HIV-2 ROD and SIV MAC; and the env, nef, vif, and vpu genes of HIV-1 Bru, HIV-1 Mal and HIV-1 Eli and nucleotide sequences complementary thereto.

 
Web www.patentalert.com

< Covalently fixed porphyrin polymer having porphyrin metal complex substituted with coordinating hetero aromatic ring as constituting unit thereof,and method of producing the same

< Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

> Herbal nutraceutical formulation for diabetics and process for preparing the same

> Extracellular rage binding protein (EN-RAGE) and uses thereof

~ 00275